Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

430 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential.
Waingankar N, Martini A, Griffiths L, Shah P, Paulucci DJ, Kotamarti S, Gul Z, Elmasri M, Yaskiv O, Haines K, Lerner S, Vira M, Kavoussi LR, Tewari AK, Kapoor DA, Olsson CA. Waingankar N, et al. Among authors: olsson ca. Urol Oncol. 2020 Mar;38(3):78.e15-78.e21. doi: 10.1016/j.urolonc.2019.10.009. Epub 2019 Dec 1. Urol Oncol. 2020. PMID: 31796374
Utilization trends in prostate cancer therapy.
Kapoor DA, Zimberg SH, Ohrin LM, Underwood W 3rd, Olsson CA. Kapoor DA, et al. Among authors: olsson ca. J Urol. 2011 Sep;186(3):860-4. doi: 10.1016/j.juro.2011.04.075. Epub 2011 Jul 23. J Urol. 2011. PMID: 21788052
Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies.
Rastinehad AR, Waingankar N, Turkbey B, Yaskiv O, Sonstegard AM, Fakhoury M, Olsson CA, Siegel DN, Choyke PL, Ben-Levi E, Villani R. Rastinehad AR, et al. Among authors: olsson ca. PLoS One. 2015 Nov 25;10(11):e0143404. doi: 10.1371/journal.pone.0143404. eCollection 2015. PLoS One. 2015. PMID: 26605548 Free PMC article.
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation.
Tward J, Lenz L, Flake DD II,, Rajamani S, Yonover P, Olsson C, Kapoor DA, Mantz C, Liauw SL, Antic T, Fabrizio M, Salzstein D, Shore N, Albertson D, Henderson J, Lee SP, Gay HA, Michalski J, Hung A, Raben D, Garraway I, Lewis MS, Nguyen PL, Marshall DT, Brawer MK, Stone S, Cohen T. Tward J, et al. Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):66-76. doi: 10.1016/j.ijrobp.2021.09.034. Epub 2021 Oct 3. Int J Radiat Oncol Biol Phys. 2022. PMID: 34610388 Free article.
430 results